SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Boehringer Ingelheim GmbH

Headquarters : Binger Strasse 173 55216 Ingelheim Germany Germany tel. 49-6132-770 analytics

Brands

name
click to compare prices
Activis, Aggrenox
Boeringer Ingelheim
Micardis
Roxane Laboratories
Spiriva
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Boehringer Ingelheim GmbH , group Boehringer and subsidiaries

Fraud 1 Offshore 1 Influence 4
[click on the rating for the method or on the number for the data]
shareholdercountry%source
BoehringerGermany100
» More shareholders of Boehringer Ingelheim GmbH
year
business
source
2006Boehringer Ingelheim is the world's fifteenth-largest pharmaceutical group.Les Echos
» More business descriptions and market shares for Boehringer Ingelheim GmbH.
country
address & contact : production type
incentive source
China China
Shanghai : médicaments
 Les Echos
South Korea South Korea
:
 Les Echos
Indonesia Indonesia
:
 Les Echos
Ireland Ireland
Dublin : R&D
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Les Echos
Taiwan Taiwan
:
 Les Echos
» More locations of Boehringer Ingelheim GmbH
» The World map of tax haven, secret accounts and shell companies

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2000Johann, Heribert
See the photo of: Johann, Heribert Chairman;
1999Heribert,
See the photo of: Heribert, Chairman;
» More executive salaries for Boehringer Ingelheim GmbH
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2007
40000
 Les Echos
1999
26448
» More restructuring at Boehringer Ingelheim GmbH
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 2 informations, access to subscribers
» More restructuring at Boehringer Ingelheim GmbH
» Layoff plans and labour conditions in 2007

  • Subsidy

  • Advertising & marketing

year  salesincome source
2007   10,9   billion Eu€Les Echos
2006   11   billion US$Les Echos
1999   5,390,26   billion Eu€
» More financial data for Boehringer Ingelheim GmbH
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 3 informations, access to subscribers
» More financial data for Boehringer Ingelheim GmbH
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
2000lift the ban on bovine growth hormon : FEDESA : : European Commission translateFedesa
1999Deregulation and "maximum liberalization" through WTO, GATS : TABD (Transatlantic Business Dialogue) : : US Government / European Commission translateCorporate Europe Observatory
» More influence from Boehringer Ingelheim GmbH
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 4 informations, access to subscribers
» More influence from Boehringer Ingelheim GmbH
» Influence in 2007
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS